Edition:
United States

Arsanis Inc (ASNS.OQ)

ASNS.OQ on NASDAQ Stock Exchange Global Market

16.65USD
25 May 2018
Change (% chg)

$0.90 (+5.71%)
Prev Close
$15.75
Open
$15.00
Day's High
$16.81
Day's Low
$14.95
Volume
14,146
Avg. Vol
10,881
52-wk High
$27.83
52-wk Low
$10.50

Select another date:

Thu, May 10 2018

BRIEF-Arsanis Posts Qtrly Loss Per Share $0.74

* ASN100 PHASE 2 TRIAL INTERIM ANALYSIS RESULTS EXPECTED IN LATE JUNE

BRIEF-Arsanis Inc - Out Licenses Preclinical Stage E. Coli Monoclonal Antibodies

* BB100 SECURED EXCLUSIVE,WORLDWIDE PRECLINICAL DEVELOPMENT LICENSE, OPTION TO DEVELOPMENT, COMMERCIALIZATION LICENSE, TO MABS TARGETING E. COLI Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Arsanis Granted Key Patents For ASN100 Covering Cross-Neutralizing S. Aureus Toxin Antibodies

* ARSANIS GRANTED KEY PATENTS FOR ASN100 COVERING CROSS-NEUTRALIZING S. AUREUS TOXIN ANTIBODIES Source text for Eikon: Further company coverage:

BRIEF-Arsanis Reports Q4 Net Loss $1.68 Per Share

* ARSANIS REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR FOURTH QUARTER AND FULL YEAR 2017

BRIEF-Arsanis Inc Files To Say It Has Raised $20 Million In Equity Financing - SEC Filing

* ARSANIS INC FILES TO SAY IT HAS RAISED $20 MILLION IN EQUITY FINANCING - SEC FILING Source text (http://bit.ly/2AvvJ48) Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

BRIEF-New Enterprise Associates 16 L.P. Reports 14.6 Percent Stake In Arsanis As Of Nov 20

* NEW ENTERPRISE ASSOCIATES 16 L.P. REPORTS A 14.6 PERCENT STAKE IN ARSANIS AS OF NOVEMBER 20, 2017 - SEC FILING Source text : [ID:http://bit.ly/2ncluP0] Further company coverage:

Select another date: